The V617F mutation of the Janus kinase protein, JAK2, is the most prevalent genetic abnormality in these three types of MPN and is found in 95% of PV, and about 50% of ET and PMF [1–4]. Here, JAK2 is linked to myeloproliferative neoplasm.